Journal of Clinical Pathology · 2020 · 28 citations · 19 references
MedicineOncologyUrologyGenitourinary OncologyNeoplasiaUrologic OncologyBiomarkers In Genitourinary CancerBiomarkers In Urologic OncologyBladder CancerUrinary CytologyUrologic Cancer DiagnosisUrothelial CarcinomaAtypical Urothelial CellsBladder Cancer CytologyBladder Cancer DiagnosisDna Methylation BiomarkersMethylation BiomarkersUrine Cytology MarkersUrothelial Carcinoma CytologyVoided Urine Cytology
AIMS: Bladder EpiCheck is one of several urinary tests studied to identify bladder tumours and analyses 15 methylation biomarkers determining bladder cancer presence on the basis of methylation profile. METHODS: 374 patients diagnosed with high-grade non-muscle invasive bladder cancer were treated and followed for 1 year with voided urine cytology and white-light cystoscopy and biopsies according to European Association of Urology Guidelines. 268 cases were diagnosed with high-grade papillary carcinoma, while 106 cases were carcinoma in situ. Bladder EpiCheck test was performed together with cytology in all cases. RESULTS: Comparing cytological categories of negative for high-grade urothelial carcinoma (NHGUC) and atypical urothelial cells (AUCs), we found that an EpiScore <60 correlates with NHGUC (p=0.0003, Fisher's exact test), while comparing AUC and suspicious for high-grade urothelial carcinoma (SHGUC) or SHGUC and high-grade urothelial carcinoma (HGUC) categories, an EpiScore ≥60 correlates with SHGUC and HGUC, respectively (p=0.0031 and p=0.0027, Fisher's exact test). In each TPS category, we found that sensitivity, specificity, Positive Predicitve Value (PPV) and Negative Predictive Value (NPV) of the Bladder EpiCheck test in HGUC category were higher than those observed in SHGUC group (sensitivity=98%, specificity=100%, NPV=85.7%, PPV=100% vs sensitivity=86.6%, specificity=52.3%, NPV=84.6%, PPV=56.5%). CONCLUSIONS: Analysing methylation study results, we demonstrated that different TPS cytological categories also carry a distinct molecular signature. Moreover, our results confirm that cytological categories SHGUC and HGUC are different entities also from a molecular point of view and should continue to represent distinct groups in TPS.
19
J. Alfred Witjes, Juan Moróte, Erik B. Cornel et al. · European Urology Oncology · 2018 · 181 citations · Full text
Accuracy of Urine Cytology and the Significance of an Atypical Category
Fadi Brimo, Robin T. Vollmer, Bruce W. Case et al. · American Journal of Clinical Pathology · 2009 · 160 citations · Full text
Nomenclature for Runt-related (RUNX) proteins
André J. van Wijnen, Gary S. Stein, J. Peter Gergen et al. · Oncogene · 2004 · 120 citations
David D’Andrea, Francesco Soria, Sonja Zehetmayer et al. · British Journal of Urology · 2019 · 107 citations · Full text
Evaluation of atypical urine cytology progression to malignancy
Julianne M. Ubago, Vikas Mehta, Eva M. Wojcik et al. · Cancer Cytopathology · 2013 · 86 citations